Iron deficiency and/or iron deficiency anemia (IDA) complicate nearly 50% of pregnancies
globally, negatively impacting both maternal and fetal outcomes. Iron deficiency can cause a …

Contemporary intravenous iron formulations allow administration of high doses of elemental
iron and enable correction of total iron deficit in one or two infusions. An important but …

Introduction: The newest intravenous (IV) iron products show an improved safety profile over
predecessors, allowing for the rapid administration of relatively high doses. Ferric …

Objective Intravenous iron—a common treatment for anaemia and iron deficiency due to
inflammatory bowel disease (IBD)—can cause hypophosphataemia. This trial compared the …

Iron deficiency is a common cause of morbidity and can arise as a consequence or
complication from many diseases. The use of intravenous iron has increased significantly in …

Abstract Tumor-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a
rare acquired paraneoplastic disease that is challenging to diagnose and treat. TIO is …

Iron deficiency commonly contributes to the anemia affecting individuals with chronic kidney
disease. This review describes diagnostic criteria for iron deficiency in chronic kidney …

Refeeding syndrome (RS) is characterized by electrolyte imbalances that can occur in
malnourished and abruptly refed patients. Typical features of RS are hypophosphatemia …

The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose
(FDI) offer the possibility of administering a large amount of iron in one infusion. This results …

Some, but not all, intravenous iron formulations have been recognized to induce renal
phosphate wasting syndrome. Most commonly this has been reported following treatment of …